AllerGen NCE Inc. (AllerGen), the Allergy, Genes and Environment Network, is a national research network whose mission is to help Canadians address the challenges of living with asthma, allergies, anaphylaxis and related immune diseases.
AllerGen was established in 2004 by Innovation, Science and Economic Development Canada (formerly Industry Canada) through the Networks of Centres of Excellence (NCE) Program.
For more than a decade, AllerGen research teams have generated new knowledge; advanced drug development; built a solid foundation for significant health discoveries; forged a strong national and international research and knowledge-sharing network in allergy, asthma, and anaphylaxis; and expanded related research and clinical training opportunities to nurture a new generation of leaders in the field.
In 2016-2017, AllerGen received $5,216,500 in funding from the NCE program. Through strong partnerships and investments in research and innovative capacity-building programming relevant to partners and stakeholders, AllerGen secured additional non-NCE funding at the ratio of $1.84 to every NCE dollar received.
2016-2017 Network Performance
"At-a-Glance"
347 trainees and young professionals, research associates and technicians
160 network participants (full-time equivalent)
142 partner organizations across academia, industry, not-for-profit and government sectors
98 network investigators
34 active research projects and strategic initiatives
33 international partners